G1 Therapeutics, Inc.
GTHX · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$48 | -$148 | -$148 | -$99 |
| Dep. & Amort. | $1 | $1 | $0 | $1 |
| Deferred Tax | $1 | $0 | $1 | -$1 |
| Stock-Based Comp. | $15 | $21 | $22 | $19 |
| Change in WC | -$5 | -$5 | -$9 | -$4 |
| Other Non-Cash | -$1 | $3 | $2 | $1 |
| Operating Cash Flow | -$38 | -$129 | -$132 | -$84 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | $0 | $0 |
| Net Acquisitions | $0 | $50 | $0 | $0 |
| Inv. Purchases | -$125 | -$65 | $0 | $0 |
| Inv. Sales/Matur. | $128 | $15 | $0 | $0 |
| Other Inv. Act. | $3 | -$50 | $0 | $0 |
| Investing Cash Flow | $3 | -$51 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$27 | $0 | $55 | $20 |
| Stock Issued | -$0 | $52 | $86 | $2 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | $0 | $4 | $2 |
| Financing Cash Flow | -$27 | $52 | $146 | $22 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$62 | -$127 | $14 | -$62 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $95 | $222 | $208 | $270 |
| End Cash | $32 | $95 | $222 | $208 |
| Free Cash Flow | -$38 | -$129 | -$132 | -$84 |